These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8658045)

  • 1. Hepatotoxicity due to lysine salt of bendazac.
    Alcalde M; Garcia-Diaz M; Najarro F; Donoso MS; Cebria L; Pascasio JM
    Scand J Gastroenterol; 1996 Feb; 31(2):206-8. PubMed ID: 8658045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bendazac hepatotoxicity: analysis of 16 cases].
    Prieto de Paula JM; Rodríguez Rodríguez E; Villamandos Nicás V; Sanz de la Fuente H; Prada Mínguez A; del Portillo Rubí A
    Rev Clin Esp; 1995 Jun; 195(6):387-9. PubMed ID: 7644786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts.
    Balfour JA; Clissold SP
    Drugs; 1990 Apr; 39(4):575-96. PubMed ID: 2190795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychophysical and electrofunctional contrast sensitivity in cataractous patients treated with bendazac-lysine salt.
    Ponte F; Giuffrè G; Cuttitta A
    Doc Ophthalmol; 1990-1991; 76(3):285-96. PubMed ID: 2103531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bendazac lysine in selected types of human senile cataract. A long-term double-masked placebo-controlled clinical trial with multilinear densitometric image analysis of Scheimpflug photographs.
    Hockwin O; Laser H; De Gregorio M; Carrieri MP
    Ophthalmic Res; 1989; 21(3):141-54. PubMed ID: 2674821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic data supporting the use of the l-lysine salt of bendazac in cataract.
    Silvestrini B; Catanese B; Barillari G; Iorio E; Valeri P
    Int J Tissue React; 1983; 5(2):217-25. PubMed ID: 6618787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bendazac and benzydamine for treatment of cataract: individualized therapy by the "BLOA test".
    Testa M; Iuliano G; Marino E; Buongiovanni C; Paolercio F; Trapanese A; Mortow P
    J Ocul Pharmacol; 1986; 2(3):251-66. PubMed ID: 3503111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxic and autoimmune type I-like hepatitis and hyporegenerative anemia caused by bendazac].
    Alcalde M; García-Díaz M; Najarro F; Pascasio JM
    Rev Esp Enferm Dig; 1994 May; 85(5):404-5. PubMed ID: 8049115
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatotoxicity due to bindazac.
    Ballesteros JA; Badosa AM; Usandizaga I; Amengual M
    Lancet; 1987 Oct; 2(8566):1030-1. PubMed ID: 2889942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxic hepatitis caused by bendazac].
    Prieto de Paula JM; Cancelo Suárez P; Villamandos Nicás V; Sánchez Sánchez A
    Med Clin (Barc); 1993 May; 100(20):798. PubMed ID: 8321062
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fulminant liver failure due to bendazac].
    Hermo JA; Pineda JR; Alfonsín N; Rodríguez A
    Med Clin (Barc); 1995 Mar; 104(10):396. PubMed ID: 7707735
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fulminant liver failure due to bendazac].
    Laporte JR; Capellà D
    Med Clin (Barc); 1995 Mar; 104(10):396. PubMed ID: 7707736
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic active hepatitis due to bendazac].
    Rodríguez Rodríguez E; Prieto de Paula JM; Cancelo Suárez P; Echevarría Iturbe C
    Rev Clin Esp; 1994 Aug; 194(8):657-8. PubMed ID: 7938854
    [No Abstract]   [Full Text] [Related]  

  • 14. Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac.
    Marques C; Ramalho JS; Pereira P; Mota MC
    Doc Ophthalmol; 1995; 90(4):395-404. PubMed ID: 8620822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis due to bendazac and alclometasone dipropionate.
    Iwakiri K; Hata M; Miura Y; Numano K; Yuge M; Sasaki E
    Contact Dermatitis; 1999 Oct; 41(4):218-39. PubMed ID: 10515101
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical study of bendazac lysine for in vivo contact lens cleaning.
    Evans TC; Levy B; Szabocsik J
    Optom Vis Sci; 1993 Mar; 70(3):210-5. PubMed ID: 8483582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses.
    Soldo L; Ruggieri A; Milanese C; Pinza M; Guglielmotti A
    Ophthalmic Res; 2004; 36(3):145-50. PubMed ID: 15103205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of senile cataract: clinical investigation of bendazac-lysine using objective and subjective methods.
    Baraldi P; Fonda S; Toschi P; Benassi B; Luppi ML; Penne A; Mazza C; Bocca E
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(2):105-11. PubMed ID: 2338248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluations of novel bendazac lysine analogues as potent anticataract agents.
    Shen H; Gou S; Shen J; Zhu Y; Zhang Y; Chen X
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2115-8. PubMed ID: 20223660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of bendazac for treatment of cataract.
    Testa M; Iuliano G; Silvestrini B
    Lancet; 1982 Apr; 1(8276):849-50. PubMed ID: 6122073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.